Clinical Trial Update: Phase I/II Randomized Clinical Trial of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells Systemic Infusion in Severe Systemic Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II randomized clinical trial evaluating systemic infusion of allogeneic adipose tissue-derived mesenchymal stromal cells for severe systemic sclerosis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Allogeneic adipose tissue-derived mesenchymal stromal cells (mesenchymal stromal cells)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Severe Systemic Sclerosis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING